Dictionary

The Dictionary provides concise definitions of health economics terms, arranged alphabetically for quick reference. Use it to understand unfamiliar terminology or confirm the meaning of a specific term.

51–100 of 152 terms matching “HAS”

C

Consolidation TherapyConsolidation Treatment, Post-Induction Therapy
A treatment given after successful induction therapy has reduced disease burden, intended to eliminate remaining disease and reduce relapse risk.
Contact CoveragePopulation Contact Reach, First-Contact Uptake
A measure of the proportion of a target population that has received at least one contact with a specific service, an early coverage step.
Contact RateContact Frequency, Mixing Rate
Contact rate is the expected number of defined, potentially transmission-relevant encounters an individual has per unit time in an infectious-disease model.
Continuous CoverageUninterrupted Coverage, Gap-Free Coverage
A period during which an individual has maintained insurance without a significant gap, sometimes a qualifying condition for guaranteed issue rights.
Continuous Quality ImprovementCQI, Kaizen in Healthcare
An organisational philosophy emphasising ongoing, incremental efforts to improve healthcare processes and outcomes, rather than a one-time project.
Convergence AssessmentConvergence Diagnostics, MCMC Diagnostics
An evaluation of whether an iterative algorithm, such as a Markov chain Monte Carlo simulation, has run enough iterations to produce stable results.
Covered ServiceCovered Benefit, Reimbursable Service
A healthcare service for which an insurance plan has agreed to pay, subject to the plan's specific terms and cost-sharing requirements.
Credence GoodCredence Product, Trust Good
A good whose quality or necessity cannot be reliably judged by the consumer even after purchase, since doing so needs specialist expertise they lack.
Currency ConversionExchange-Rate Conversion, Currency Translation
The translation of cost or price data from one national currency into another, typically using exchange rates or purchasing power parity.

D

DMAICDefine Measure Analyse Improve Control, Six Sigma Improvement Cycle
A structured, five-phase Six Sigma methodology, Define, Measure, Analyse, Improve, Control, for identifying and addressing root causes of a quality problem.
Dose-Limiting ToxicityDLT, Dose-Limiting Adverse Event
A sufficiently severe adverse event in early-phase trials that prevents further dose escalation, used to help determine the maximum tolerated dose.
Drug PricingPharmaceutical Pricing, Medicine Price Setting
The setting and negotiation of medicine prices and payments across a specified product, purchaser, market and point in the supply chain.

E

Early InterventionEarly Treatment, First-Episode Intervention
A mental health care approach emphasising identifying and treating conditions at their earliest stages, often targeting first signs of serious illness.
Emergency Care CoverageEmergency Access Coverage, Emergency Service Reach
A measure of the extent to which a population has timely access to needed emergency medical services, reflecting response capacity.
End Of Life Economics OncologyEoL Oncology Economics, Advanced Cancer End-of-Life Economics
The application of health economic evaluation to care during advanced cancer's final phase, weighing continued aggressive treatment against palliative or hospice care.
End-of-Life Care EconomicsEoL Care Economics, End-of-Life Economics
The application of health economic evaluation to care during a life-limiting illness's final phase, covering palliative management, hospice, and treatment intensity decisions.
End-Stage Renal DiseaseESRD, End-Stage Kidney Disease
The most severe stage of chronic kidney disease, where kidney function has declined to require dialysis or transplantation to sustain life.
Evaluation StandardsStudy Conduct Criteria, Appraisal Standards
The criteria used to assess whether a research study has been conducted appropriately and achieved its intended objectives, scientifically and ethically.
Evidence UpdateAssessment Update, Guideline Refresh
A revision to a previously completed assessment or guideline incorporating newly available evidence that has emerged since it was conducted.
Evidence-Based MedicineEBM, Evidence-Based Practice
An approach to clinical practice emphasising conscientious, explicit use of current best research evidence, integrated with clinical expertise and patient values.
Ex-Ante EvaluationBefore-Implementation Evaluation, Forward-Looking Evaluation
An economic evaluation conducted before an intervention has been implemented, typically relying on modelled projections rather than observed outcome data.
Ex-Post EvaluationAfter-Implementation Evaluation, Outcome-Based Evaluation
An economic evaluation conducted after an intervention has been implemented, using observed data on its actual costs and outcomes.

F

Fully Insured PlanFully-Insured Arrangement, Insured Plan
An arrangement where an employer purchases coverage from an insurer that assumes the financial risk for claims, unlike a self-insured plan.

G

GatekeepingSequential Testing Strategy, Priority-Ordered Testing
A multiple testing strategy in which a lower-priority endpoint is only formally tested if a higher-priority endpoint has already achieved significance.
Generic Entry ImpactGeneric Competition Impact, Post-Patent Impact
The effect generic competition has on a drug's market price, utilisation, and overall budget impact, typically bringing substantial price declines.
Global HealthWorld Health, Planetary Health
An area of study and practice prioritising improving health and equity worldwide, emphasising transnational issues that transcend national boundaries.
Group MarketEmployer-Sponsored Market, Group Coverage Segment
The insurance market segment in which coverage is purchased by an employer or organisation on behalf of a defined member group.

H

Health Insurance MarketInsurance Market, Health Coverage Market
The overall system through which insurance products are offered, purchased, and regulated, encompassing the individual, small group, and large group segments.
Health System FinancingHealth Financing, Healthcare Financing
Health system financing comprises the arrangements through which money for health is raised, pooled and used to purchase services in pursuit of access, equity, financial protection and efficiency.
Health System OrganizationHealth System Structure, System Organisation
The arrangement of authority, financing and purchasing institutions, care providers, and patient pathways within a health system, including how those actors coordinate and are held accountable.
Hearing Care CoverageHearing Service Coverage, Audiology Coverage
A measure of the extent to which a population has access to needed hearing loss diagnosis, treatment, and rehabilitation services.
Heart Failure EconomicsHF Economics, Cardiac Failure Economics
The application of health economic evaluation to heart failure diagnosis, medication, device therapy, and rehabilitation, emphasising reduced hospital readmission.
Hospital Care CoverageInpatient Coverage, Hospital Service Coverage
A measure of the extent to which a population has timely access to needed inpatient hospital services.

I

IndicationApproved Use, Licensed Use
The specific medical condition or use for which a drug has received regulatory approval and is intended to be prescribed.
Individual Market
The insurance market segment where coverage is purchased directly by individual consumers rather than through an employer or other group.
Information AsymmetryAsymmetric Information, Information Imbalance
Information asymmetry occurs when one party to an economic decision has more or better information than another, affecting choices, bargaining power and the efficiency of resulting outcomes.
International HealthDeveloping-Country Health, Overseas Health
A traditional field focused on health issues primarily affecting developing countries, emphasising knowledge transfer from wealthier to poorer nations.
InvestigationFormal Inquiry, Fact-Finding Inquiry
A formal inquiry gathering facts to determine whether a suspected compliance violation, fraud, or other misconduct has occurred.

J

Judicial ReviewLegal Challenge, Court Review
A legal process examining whether a government body has acted lawfully, typically focused on procedural fairness rather than scientific merit.

L

Leave-One-Out
A cross-validation form repeatedly refitting a model using all but one observation, using that observation to test accuracy, until each has served once.
Lifetime PrevalenceCumulative Prevalence, Ever-Prevalence
The proportion of a population that has experienced a condition at any point in life up to assessment, unlike point prevalence.
Log-Logistic DistributionFisk Distribution, Loglogistic AFT Model
A two-parameter continuous distribution for positive event times whose logarithm is logistic; its survival function has a heavy tail, and its hazard may rise and then fall.

M

Maintenance TherapyContinuation Therapy, Sustaining Treatment
Ongoing treatment given after an initial, more intensive phase to sustain a positive response and prevent relapse or progression.
Markov ChainMarkov Process, Discrete Markov Process
A Markov chain is a stochastic process that moves among a defined set of states such that the probability of the next state depends on the current state and specified covariates, not on the earlier path once that information is represented.
Maximum Tolerated DoseMTD, Highest Tolerated Dosage
The highest drug dose that can be given without unacceptable toxicity, typically found during early-phase trials through dose escalation.
Mental Health Service CoverageBehavioural Health Coverage, Psychiatric Service Coverage
A measure of the extent to which a population has access to needed mental health diagnosis and treatment services.
MonopsonySingle-Buyer Market, Buyer Monopoly
A market structure in which a single buyer accounts for all or most purchases of a good, giving it power to push the price down.

N

Net Present ValueNPV, Discounted Net Value
Net present value is the sum of monetary net flows at different times after each has been discounted to a common valuation date, including the initial flow.

P

Participation RestrictionICF Participation, Role Restriction
A problem an individual has engaging in normal life situations, such as employment or social activity, per the WHO functioning and disability framework.
Patient ResponsibilityPatient Financial Responsibility, Patient Liability
The total amount a patient owes for services after insurance has been applied, covering any deductible, copayment, coinsurance, or non-covered amounts.